Sale of 294 shares at $1.99 per share.
Reporting Person Miller Mary · Officer Title Chief Legal Officer · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0000905148-26-004399 · filed 2026-10-07 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Acrivon Therapeutics, Inc. (ACRV)." Disclosed 2026-10-07. https://desqlong.com/cards/0000905148-26-004399-1 (retrieved 2026-10-08).